#AI in #Oncology: From Hype to Help 🤖🤝 Oncologists today face more data than ever, genomic profiles, imaging, evolving guidelines, and complex therapy choices. What’s changing fast is how they synthesize it all. That’s where oncology is headed, from AI hype to AI help. The real transformation is happening quietly, at the point of care: 🔹 @ASCO’s Gemini Guidelines Assistant turning clinical evidence into instant, trustworthy answers. 🔹 OpenAI and @PendaHealth, outside oncology, but proof that workflow-native AI can safely reduce diagnostic and treatment errors in real clinics. 🔹 @arteraAI’s prostate test — the first AI model ever integrated into National Comprehensive Cancer Network® (NCCN®) Guidelines. 🔹 Yonsei Cancer Center’s multimodal AI system weaving together pathology, radiology, and genomics into one living patient story. The oncologist of tomorrow won’t be alone in front of the data storm. They’ll have an AI partner, one that doesn’t decide for them, but helps them decide better. Read the full CancerWorld article 👇 cancerworld.net/ai-in-oncolo… ✍🏻 Written by Dr. @amil__dr @OncoDaily, @yonsei_u, @googlecloud, @CancerLeagues, @GeminiApp, #AIinOncology #ClinicalDecisionSupport #DigitalOncology #ArtificialIntelligence #PrecisionMedicine #HealthcareInnovation #ArteraAI #ASCO #OpenAI #OncologyLeadership #AIandMedicine #FutureOfHealthcare #CancerWorld, #OncoDaily